Trump Selects White House Aide Heidi Overton to Head FDA

President Donald Trump has selected Heidi Overton, a White House policy aide, to serve as the next commissioner of the US Food and Drug Administration (FDA). The choice was reported on Tuesday, with a person familiar with the decision confirming the pick.

Overton, who has been part of the administration's domestic policy team, would step into one of the most consequential regulatory roles in American healthcare if the appointment is formalised. The FDA oversees drug approvals, food safety, and medical device regulation, making the position critical to public health and the pharmaceutical industry.

The report could not be independently verified at the time of writing. No official announcement has been made by the White House, and it remains unclear when an announcement might come or whether the nomination would require Senate confirmation.

If appointed, Overton would inherit an agency navigating ongoing challenges, including drug pricing debates, regulatory modernisation, and public health preparedness. Her background in policy work within the White House suggests a focus on aligning FDA operations with the administration's broader health agenda.